Global Contraceptives Drugs and Devices Supply, Demand and Key Producers, 2023-2029

Description

The global Contraceptives Drugs and Devices market size is expected to reach $ 43250 million by 2029, rising at a market growth of 5.7% CAGR during the forecast period (2023-2029).

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Contraceptives are birth spacing products that aid in avoiding unwanted/ unplanned pregnancy. There are five widely used contraceptive methods namely barrier method, hormonal method, emergency contraception, intrauterine method, and sterilization. Women can opt for wide range of contraceptive options such as vaginal rings, diaphragms, female condoms, oral pills, and intra-uterine devices (IUD). Selecting the most appropriate method is critical to avoid undesired side effects.

This report studies the global Contraceptives Drugs and Devices demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Contraceptives Drugs and Devices, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Contraceptives Drugs and Devices that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Contraceptives Drugs and Devices total market, 2018-2029, (USD Million)
Global Contraceptives Drugs and Devices total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Contraceptives Drugs and Devices total market, key domestic companies and share, (USD Million)
Global Contraceptives Drugs and Devices revenue by player and market share 2018-2023, (USD Million)
Global Contraceptives Drugs and Devices total market by Type, CAGR, 2018-2029, (USD Million)
Global Contraceptives Drugs and Devices total market by Application, CAGR, 2018-2029, (USD Million).

This reports profiles major players in the global Contraceptives Drugs and Devices market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Teva Pharmaceutical Industries Ltd, Church & Dwight Co. Inc, Reckitt Benckiser Plc, Pfizer, Inc, Bayer AG, Mayer Laboratories, Inc, The Female Health Company, Cooper Surgical, Inc and Allergan plc, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Contraceptives Drugs and Devices market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Contraceptives Drugs and Devices Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Contraceptives Drugs and Devices Market, Segmentation by Type
    Contraceptive Drugs (Oral Contraceptive Pills, Contraceptive Injectables, Topical Contraceptives)
    Contraceptive Devices (Male Contraceptive Devices, Female Contraceptive Devices)

Global Contraceptives Drugs and Devices Market, Segmentation by Application
    Female
    Male

Companies Profiled:
    Teva Pharmaceutical Industries Ltd
    Church & Dwight Co. Inc
    Reckitt Benckiser Plc
    Pfizer, Inc
    Bayer AG
    Mayer Laboratories, Inc
    The Female Health Company
    Cooper Surgical, Inc
    Allergan plc
    Cipla Limited
    Merck & Co. Inc
    Veru, Inc
    Organon Group of Companies
    Agile Therapeutics
    TherapeuticsmMD, Inc
    Afaxys, Inc
    Mithra Pharmaceuticals
    Abbvie

Key Questions Answered
1. How big is the global Contraceptives Drugs and Devices market?
2. What is the demand of the global Contraceptives Drugs and Devices market?
3. What is the year over year growth of the global Contraceptives Drugs and Devices market?
4. What is the total value of the global Contraceptives Drugs and Devices market?
5. Who are the major players in the global Contraceptives Drugs and Devices market?

Table of Contents

1 Supply Summary
    1.1 Contraceptives Drugs and Devices Introduction
    1.2 World Contraceptives Drugs and Devices Market Size & Forecast (2018 & 2022 & 2029)
    1.3 World Contraceptives Drugs and Devices Total Market by Region (by Headquarter Location)
        1.3.1 World Contraceptives Drugs and Devices Market Size by Region (2018-2029), (by Headquarter Location)
        1.3.2 United States Contraceptives Drugs and Devices Market Size (2018-2029)
        1.3.3 China Contraceptives Drugs and Devices Market Size (2018-2029)
        1.3.4 Europe Contraceptives Drugs and Devices Market Size (2018-2029)
        1.3.5 Japan Contraceptives Drugs and Devices Market Size (2018-2029)
        1.3.6 South Korea Contraceptives Drugs and Devices Market Size (2018-2029)
        1.3.7 ASEAN Contraceptives Drugs and Devices Market Size (2018-2029)
        1.3.8 India Contraceptives Drugs and Devices Market Size (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Contraceptives Drugs and Devices Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Contraceptives Drugs and Devices Major Market Trends

2 Demand Summary
    2.1 World Contraceptives Drugs and Devices Consumption Value (2018-2029)
    2.2 World Contraceptives Drugs and Devices Consumption Value by Region
        2.2.1 World Contraceptives Drugs and Devices Consumption Value by Region (2018-2023)
        2.2.2 World Contraceptives Drugs and Devices Consumption Value Forecast by Region (2024-2029)
    2.3 United States Contraceptives Drugs and Devices Consumption Value (2018-2029)
    2.4 China Contraceptives Drugs and Devices Consumption Value (2018-2029)
    2.5 Europe Contraceptives Drugs and Devices Consumption Value (2018-2029)
    2.6 Japan Contraceptives Drugs and Devices Consumption Value (2018-2029)
    2.7 South Korea Contraceptives Drugs and Devices Consumption Value (2018-2029)
    2.8 ASEAN Contraceptives Drugs and Devices Consumption Value (2018-2029)
    2.9 India Contraceptives Drugs and Devices Consumption Value (2018-2029)

3 World Contraceptives Drugs and Devices Companies Competitive Analysis
    3.1 World Contraceptives Drugs and Devices Revenue by Player (2018-2023)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Contraceptives Drugs and Devices Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Contraceptives Drugs and Devices in 2022
        3.2.3 Global Concentration Ratios (CR8) for Contraceptives Drugs and Devices in 2022
    3.3 Contraceptives Drugs and Devices Company Evaluation Quadrant
    3.4 Contraceptives Drugs and Devices Market: Overall Company Footprint Analysis
        3.4.1 Contraceptives Drugs and Devices Market: Region Footprint
        3.4.2 Contraceptives Drugs and Devices Market: Company Product Type Footprint
        3.4.3 Contraceptives Drugs and Devices Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Contraceptives Drugs and Devices Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Contraceptives Drugs and Devices Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
        4.1.2 United States VS China: Contraceptives Drugs and Devices Revenue Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States Based Companies VS China Based Companies: Contraceptives Drugs and Devices Consumption Value Comparison
        4.2.1 United States VS China: Contraceptives Drugs and Devices Consumption Value Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Contraceptives Drugs and Devices Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States Based Contraceptives Drugs and Devices Companies and Market Share, 2018-2023
        4.3.1 United States Based Contraceptives Drugs and Devices Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Contraceptives Drugs and Devices Revenue, (2018-2023)
    4.4 China Based Companies Contraceptives Drugs and Devices Revenue and Market Share, 2018-2023
        4.4.1 China Based Contraceptives Drugs and Devices Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Contraceptives Drugs and Devices Revenue, (2018-2023)
    4.5 Rest of World Based Contraceptives Drugs and Devices Companies and Market Share, 2018-2023
        4.5.1 Rest of World Based Contraceptives Drugs and Devices Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Contraceptives Drugs and Devices Revenue, (2018-2023)

5 Market Analysis by Type
    5.1 World Contraceptives Drugs and Devices Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Contraceptive Drugs (Oral Contraceptive Pills, Contraceptive Injectables, Topical Contraceptives)
        5.2.2 Contraceptive Devices (Male Contraceptive Devices, Female Contraceptive Devices)
    5.3 Market Segment by Type
        5.3.1 World Contraceptives Drugs and Devices Market Size by Type (2018-2023)
        5.3.2 World Contraceptives Drugs and Devices Market Size by Type (2024-2029)
        5.3.3 World Contraceptives Drugs and Devices Market Size Market Share by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Contraceptives Drugs and Devices Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Female
        6.2.2 Male
    6.3 Market Segment by Application
        6.3.1 World Contraceptives Drugs and Devices Market Size by Application (2018-2023)
        6.3.2 World Contraceptives Drugs and Devices Market Size by Application (2024-2029)
        6.3.3 World Contraceptives Drugs and Devices Market Size by Application (2018-2029)

7 Company Profiles
    7.1 Teva Pharmaceutical Industries Ltd
        7.1.1 Teva Pharmaceutical Industries Ltd Details
        7.1.2 Teva Pharmaceutical Industries Ltd Major Business
        7.1.3 Teva Pharmaceutical Industries Ltd Contraceptives Drugs and Devices Product and Services
        7.1.4 Teva Pharmaceutical Industries Ltd Contraceptives Drugs and Devices Revenue, Gross Margin and Market Share (2018-2023)
        7.1.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates
        7.1.6 Teva Pharmaceutical Industries Ltd Competitive Strengths & Weaknesses
    7.2 Church & Dwight Co. Inc
        7.2.1 Church & Dwight Co. Inc Details
        7.2.2 Church & Dwight Co. Inc Major Business
        7.2.3 Church & Dwight Co. Inc Contraceptives Drugs and Devices Product and Services
        7.2.4 Church & Dwight Co. Inc Contraceptives Drugs and Devices Revenue, Gross Margin and Market Share (2018-2023)
        7.2.5 Church & Dwight Co. Inc Recent Developments/Updates
        7.2.6 Church & Dwight Co. Inc Competitive Strengths & Weaknesses
    7.3 Reckitt Benckiser Plc
        7.3.1 Reckitt Benckiser Plc Details
        7.3.2 Reckitt Benckiser Plc Major Business
        7.3.3 Reckitt Benckiser Plc Contraceptives Drugs and Devices Product and Services
        7.3.4 Reckitt Benckiser Plc Contraceptives Drugs and Devices Revenue, Gross Margin and Market Share (2018-2023)
        7.3.5 Reckitt Benckiser Plc Recent Developments/Updates
        7.3.6 Reckitt Benckiser Plc Competitive Strengths & Weaknesses
    7.4 Pfizer, Inc
        7.4.1 Pfizer, Inc Details
        7.4.2 Pfizer, Inc Major Business
        7.4.3 Pfizer, Inc Contraceptives Drugs and Devices Product and Services
        7.4.4 Pfizer, Inc Contraceptives Drugs and Devices Revenue, Gross Margin and Market Share (2018-2023)
        7.4.5 Pfizer, Inc Recent Developments/Updates
        7.4.6 Pfizer, Inc Competitive Strengths & Weaknesses
    7.5 Bayer AG
        7.5.1 Bayer AG Details
        7.5.2 Bayer AG Major Business
        7.5.3 Bayer AG Contraceptives Drugs and Devices Product and Services
        7.5.4 Bayer AG Contraceptives Drugs and Devices Revenue, Gross Margin and Market Share (2018-2023)
        7.5.5 Bayer AG Recent Developments/Updates
        7.5.6 Bayer AG Competitive Strengths & Weaknesses
    7.6 Mayer Laboratories, Inc
        7.6.1 Mayer Laboratories, Inc Details
        7.6.2 Mayer Laboratories, Inc Major Business
        7.6.3 Mayer Laboratories, Inc Contraceptives Drugs and Devices Product and Services
        7.6.4 Mayer Laboratories, Inc Contraceptives Drugs and Devices Revenue, Gross Margin and Market Share (2018-2023)
        7.6.5 Mayer Laboratories, Inc Recent Developments/Updates
        7.6.6 Mayer Laboratories, Inc Competitive Strengths & Weaknesses
    7.7 The Female Health Company
        7.7.1 The Female Health Company Details
        7.7.2 The Female Health Company Major Business
        7.7.3 The Female Health Company Contraceptives Drugs and Devices Product and Services
        7.7.4 The Female Health Company Contraceptives Drugs and Devices Revenue, Gross Margin and Market Share (2018-2023)
        7.7.5 The Female Health Company Recent Developments/Updates
        7.7.6 The Female Health Company Competitive Strengths & Weaknesses
    7.8 Cooper Surgical, Inc
        7.8.1 Cooper Surgical, Inc Details
        7.8.2 Cooper Surgical, Inc Major Business
        7.8.3 Cooper Surgical, Inc Contraceptives Drugs and Devices Product and Services
        7.8.4 Cooper Surgical, Inc Contraceptives Drugs and Devices Revenue, Gross Margin and Market Share (2018-2023)
        7.8.5 Cooper Surgical, Inc Recent Developments/Updates
        7.8.6 Cooper Surgical, Inc Competitive Strengths & Weaknesses
    7.9 Allergan plc
        7.9.1 Allergan plc Details
        7.9.2 Allergan plc Major Business
        7.9.3 Allergan plc Contraceptives Drugs and Devices Product and Services
        7.9.4 Allergan plc Contraceptives Drugs and Devices Revenue, Gross Margin and Market Share (2018-2023)
        7.9.5 Allergan plc Recent Developments/Updates
        7.9.6 Allergan plc Competitive Strengths & Weaknesses
    7.10 Cipla Limited
        7.10.1 Cipla Limited Details
        7.10.2 Cipla Limited Major Business
        7.10.3 Cipla Limited Contraceptives Drugs and Devices Product and Services
        7.10.4 Cipla Limited Contraceptives Drugs and Devices Revenue, Gross Margin and Market Share (2018-2023)
        7.10.5 Cipla Limited Recent Developments/Updates
        7.10.6 Cipla Limited Competitive Strengths & Weaknesses
    7.11 Merck & Co. Inc
        7.11.1 Merck & Co. Inc Details
        7.11.2 Merck & Co. Inc Major Business
        7.11.3 Merck & Co. Inc Contraceptives Drugs and Devices Product and Services
        7.11.4 Merck & Co. Inc Contraceptives Drugs and Devices Revenue, Gross Margin and Market Share (2018-2023)
        7.11.5 Merck & Co. Inc Recent Developments/Updates
        7.11.6 Merck & Co. Inc Competitive Strengths & Weaknesses
    7.12 Veru, Inc
        7.12.1 Veru, Inc Details
        7.12.2 Veru, Inc Major Business
        7.12.3 Veru, Inc Contraceptives Drugs and Devices Product and Services
        7.12.4 Veru, Inc Contraceptives Drugs and Devices Revenue, Gross Margin and Market Share (2018-2023)
        7.12.5 Veru, Inc Recent Developments/Updates
        7.12.6 Veru, Inc Competitive Strengths & Weaknesses
    7.13 Organon Group of Companies
        7.13.1 Organon Group of Companies Details
        7.13.2 Organon Group of Companies Major Business
        7.13.3 Organon Group of Companies Contraceptives Drugs and Devices Product and Services
        7.13.4 Organon Group of Companies Contraceptives Drugs and Devices Revenue, Gross Margin and Market Share (2018-2023)
        7.13.5 Organon Group of Companies Recent Developments/Updates
        7.13.6 Organon Group of Companies Competitive Strengths & Weaknesses
    7.14 Agile Therapeutics
        7.14.1 Agile Therapeutics Details
        7.14.2 Agile Therapeutics Major Business
        7.14.3 Agile Therapeutics Contraceptives Drugs and Devices Product and Services
        7.14.4 Agile Therapeutics Contraceptives Drugs and Devices Revenue, Gross Margin and Market Share (2018-2023)
        7.14.5 Agile Therapeutics Recent Developments/Updates
        7.14.6 Agile Therapeutics Competitive Strengths & Weaknesses
    7.15 TherapeuticsmMD, Inc
        7.15.1 TherapeuticsmMD, Inc Details
        7.15.2 TherapeuticsmMD, Inc Major Business
        7.15.3 TherapeuticsmMD, Inc Contraceptives Drugs and Devices Product and Services
        7.15.4 TherapeuticsmMD, Inc Contraceptives Drugs and Devices Revenue, Gross Margin and Market Share (2018-2023)
        7.15.5 TherapeuticsmMD, Inc Recent Developments/Updates
        7.15.6 TherapeuticsmMD, Inc Competitive Strengths & Weaknesses
    7.16 Afaxys, Inc
        7.16.1 Afaxys, Inc Details
        7.16.2 Afaxys, Inc Major Business
        7.16.3 Afaxys, Inc Contraceptives Drugs and Devices Product and Services
        7.16.4 Afaxys, Inc Contraceptives Drugs and Devices Revenue, Gross Margin and Market Share (2018-2023)
        7.16.5 Afaxys, Inc Recent Developments/Updates
        7.16.6 Afaxys, Inc Competitive Strengths & Weaknesses
    7.17 Mithra Pharmaceuticals
        7.17.1 Mithra Pharmaceuticals Details
        7.17.2 Mithra Pharmaceuticals Major Business
        7.17.3 Mithra Pharmaceuticals Contraceptives Drugs and Devices Product and Services
        7.17.4 Mithra Pharmaceuticals Contraceptives Drugs and Devices Revenue, Gross Margin and Market Share (2018-2023)
        7.17.5 Mithra Pharmaceuticals Recent Developments/Updates
        7.17.6 Mithra Pharmaceuticals Competitive Strengths & Weaknesses
    7.18 Abbvie
        7.18.1 Abbvie Details
        7.18.2 Abbvie Major Business
        7.18.3 Abbvie Contraceptives Drugs and Devices Product and Services
        7.18.4 Abbvie Contraceptives Drugs and Devices Revenue, Gross Margin and Market Share (2018-2023)
        7.18.5 Abbvie Recent Developments/Updates
        7.18.6 Abbvie Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Contraceptives Drugs and Devices Industry Chain
    8.2 Contraceptives Drugs and Devices Upstream Analysis
    8.3 Contraceptives Drugs and Devices Midstream Analysis
    8.4 Contraceptives Drugs and Devices Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Contraceptives Drugs and Devices Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
    Table 2. World Contraceptives Drugs and Devices Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
    Table 3. World Contraceptives Drugs and Devices Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
    Table 4. World Contraceptives Drugs and Devices Revenue Market Share by Region (2018-2023), (by Headquarter Location)
    Table 5. World Contraceptives Drugs and Devices Revenue Market Share by Region (2024-2029), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Contraceptives Drugs and Devices Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
    Table 8. World Contraceptives Drugs and Devices Consumption Value by Region (2018-2023) & (USD Million)
    Table 9. World Contraceptives Drugs and Devices Consumption Value Forecast by Region (2024-2029) & (USD Million)
    Table 10. World Contraceptives Drugs and Devices Revenue by Player (2018-2023) & (USD Million)
    Table 11. Revenue Market Share of Key Contraceptives Drugs and Devices Players in 2022
    Table 12. World Contraceptives Drugs and Devices Industry Rank of Major Player, Based on Revenue in 2022
    Table 13. Global Contraceptives Drugs and Devices Company Evaluation Quadrant
    Table 14. Head Office of Key Contraceptives Drugs and Devices Player
    Table 15. Contraceptives Drugs and Devices Market: Company Product Type Footprint
    Table 16. Contraceptives Drugs and Devices Market: Company Product Application Footprint
    Table 17. Contraceptives Drugs and Devices Mergers & Acquisitions Activity
    Table 18. United States VS China Contraceptives Drugs and Devices Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 19. United States VS China Contraceptives Drugs and Devices Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 20. United States Based Contraceptives Drugs and Devices Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Contraceptives Drugs and Devices Revenue, (2018-2023) & (USD Million)
    Table 22. United States Based Companies Contraceptives Drugs and Devices Revenue Market Share (2018-2023)
    Table 23. China Based Contraceptives Drugs and Devices Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Contraceptives Drugs and Devices Revenue, (2018-2023) & (USD Million)
    Table 25. China Based Companies Contraceptives Drugs and Devices Revenue Market Share (2018-2023)
    Table 26. Rest of World Based Contraceptives Drugs and Devices Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Contraceptives Drugs and Devices Revenue, (2018-2023) & (USD Million)
    Table 28. Rest of World Based Companies Contraceptives Drugs and Devices Revenue Market Share (2018-2023)
    Table 29. World Contraceptives Drugs and Devices Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Table 30. World Contraceptives Drugs and Devices Market Size by Type (2018-2023) & (USD Million)
    Table 31. World Contraceptives Drugs and Devices Market Size by Type (2024-2029) & (USD Million)
    Table 32. World Contraceptives Drugs and Devices Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Table 33. World Contraceptives Drugs and Devices Market Size by Application (2018-2023) & (USD Million)
    Table 34. World Contraceptives Drugs and Devices Market Size by Application (2024-2029) & (USD Million)
    Table 35. Teva Pharmaceutical Industries Ltd Basic Information, Area Served and Competitors
    Table 36. Teva Pharmaceutical Industries Ltd Major Business
    Table 37. Teva Pharmaceutical Industries Ltd Contraceptives Drugs and Devices Product and Services
    Table 38. Teva Pharmaceutical Industries Ltd Contraceptives Drugs and Devices Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 39. Teva Pharmaceutical Industries Ltd Recent Developments/Updates
    Table 40. Teva Pharmaceutical Industries Ltd Competitive Strengths & Weaknesses
    Table 41. Church & Dwight Co. Inc Basic Information, Area Served and Competitors
    Table 42. Church & Dwight Co. Inc Major Business
    Table 43. Church & Dwight Co. Inc Contraceptives Drugs and Devices Product and Services
    Table 44. Church & Dwight Co. Inc Contraceptives Drugs and Devices Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 45. Church & Dwight Co. Inc Recent Developments/Updates
    Table 46. Church & Dwight Co. Inc Competitive Strengths & Weaknesses
    Table 47. Reckitt Benckiser Plc Basic Information, Area Served and Competitors
    Table 48. Reckitt Benckiser Plc Major Business
    Table 49. Reckitt Benckiser Plc Contraceptives Drugs and Devices Product and Services
    Table 50. Reckitt Benckiser Plc Contraceptives Drugs and Devices Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 51. Reckitt Benckiser Plc Recent Developments/Updates
    Table 52. Reckitt Benckiser Plc Competitive Strengths & Weaknesses
    Table 53. Pfizer, Inc Basic Information, Area Served and Competitors
    Table 54. Pfizer, Inc Major Business
    Table 55. Pfizer, Inc Contraceptives Drugs and Devices Product and Services
    Table 56. Pfizer, Inc Contraceptives Drugs and Devices Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 57. Pfizer, Inc Recent Developments/Updates
    Table 58. Pfizer, Inc Competitive Strengths & Weaknesses
    Table 59. Bayer AG Basic Information, Area Served and Competitors
    Table 60. Bayer AG Major Business
    Table 61. Bayer AG Contraceptives Drugs and Devices Product and Services
    Table 62. Bayer AG Contraceptives Drugs and Devices Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 63. Bayer AG Recent Developments/Updates
    Table 64. Bayer AG Competitive Strengths & Weaknesses
    Table 65. Mayer Laboratories, Inc Basic Information, Area Served and Competitors
    Table 66. Mayer Laboratories, Inc Major Business
    Table 67. Mayer Laboratories, Inc Contraceptives Drugs and Devices Product and Services
    Table 68. Mayer Laboratories, Inc Contraceptives Drugs and Devices Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 69. Mayer Laboratories, Inc Recent Developments/Updates
    Table 70. Mayer Laboratories, Inc Competitive Strengths & Weaknesses
    Table 71. The Female Health Company Basic Information, Area Served and Competitors
    Table 72. The Female Health Company Major Business
    Table 73. The Female Health Company Contraceptives Drugs and Devices Product and Services
    Table 74. The Female Health Company Contraceptives Drugs and Devices Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 75. The Female Health Company Recent Developments/Updates
    Table 76. The Female Health Company Competitive Strengths & Weaknesses
    Table 77. Cooper Surgical, Inc Basic Information, Area Served and Competitors
    Table 78. Cooper Surgical, Inc Major Business
    Table 79. Cooper Surgical, Inc Contraceptives Drugs and Devices Product and Services
    Table 80. Cooper Surgical, Inc Contraceptives Drugs and Devices Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 81. Cooper Surgical, Inc Recent Developments/Updates
    Table 82. Cooper Surgical, Inc Competitive Strengths & Weaknesses
    Table 83. Allergan plc Basic Information, Area Served and Competitors
    Table 84. Allergan plc Major Business
    Table 85. Allergan plc Contraceptives Drugs and Devices Product and Services
    Table 86. Allergan plc Contraceptives Drugs and Devices Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 87. Allergan plc Recent Developments/Updates
    Table 88. Allergan plc Competitive Strengths & Weaknesses
    Table 89. Cipla Limited Basic Information, Area Served and Competitors
    Table 90. Cipla Limited Major Business
    Table 91. Cipla Limited Contraceptives Drugs and Devices Product and Services
    Table 92. Cipla Limited Contraceptives Drugs and Devices Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 93. Cipla Limited Recent Developments/Updates
    Table 94. Cipla Limited Competitive Strengths & Weaknesses
    Table 95. Merck & Co. Inc Basic Information, Area Served and Competitors
    Table 96. Merck & Co. Inc Major Business
    Table 97. Merck & Co. Inc Contraceptives Drugs and Devices Product and Services
    Table 98. Merck & Co. Inc Contraceptives Drugs and Devices Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 99. Merck & Co. Inc Recent Developments/Updates
    Table 100. Merck & Co. Inc Competitive Strengths & Weaknesses
    Table 101. Veru, Inc Basic Information, Area Served and Competitors
    Table 102. Veru, Inc Major Business
    Table 103. Veru, Inc Contraceptives Drugs and Devices Product and Services
    Table 104. Veru, Inc Contraceptives Drugs and Devices Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 105. Veru, Inc Recent Developments/Updates
    Table 106. Veru, Inc Competitive Strengths & Weaknesses
    Table 107. Organon Group of Companies Basic Information, Area Served and Competitors
    Table 108. Organon Group of Companies Major Business
    Table 109. Organon Group of Companies Contraceptives Drugs and Devices Product and Services
    Table 110. Organon Group of Companies Contraceptives Drugs and Devices Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 111. Organon Group of Companies Recent Developments/Updates
    Table 112. Organon Group of Companies Competitive Strengths & Weaknesses
    Table 113. Agile Therapeutics Basic Information, Area Served and Competitors
    Table 114. Agile Therapeutics Major Business
    Table 115. Agile Therapeutics Contraceptives Drugs and Devices Product and Services
    Table 116. Agile Therapeutics Contraceptives Drugs and Devices Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 117. Agile Therapeutics Recent Developments/Updates
    Table 118. Agile Therapeutics Competitive Strengths & Weaknesses
    Table 119. TherapeuticsmMD, Inc Basic Information, Area Served and Competitors
    Table 120. TherapeuticsmMD, Inc Major Business
    Table 121. TherapeuticsmMD, Inc Contraceptives Drugs and Devices Product and Services
    Table 122. TherapeuticsmMD, Inc Contraceptives Drugs and Devices Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 123. TherapeuticsmMD, Inc Recent Developments/Updates
    Table 124. TherapeuticsmMD, Inc Competitive Strengths & Weaknesses
    Table 125. Afaxys, Inc Basic Information, Area Served and Competitors
    Table 126. Afaxys, Inc Major Business
    Table 127. Afaxys, Inc Contraceptives Drugs and Devices Product and Services
    Table 128. Afaxys, Inc Contraceptives Drugs and Devices Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 129. Afaxys, Inc Recent Developments/Updates
    Table 130. Afaxys, Inc Competitive Strengths & Weaknesses
    Table 131. Mithra Pharmaceuticals Basic Information, Area Served and Competitors
    Table 132. Mithra Pharmaceuticals Major Business
    Table 133. Mithra Pharmaceuticals Contraceptives Drugs and Devices Product and Services
    Table 134. Mithra Pharmaceuticals Contraceptives Drugs and Devices Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 135. Mithra Pharmaceuticals Recent Developments/Updates
    Table 136. Abbvie Basic Information, Area Served and Competitors
    Table 137. Abbvie Major Business
    Table 138. Abbvie Contraceptives Drugs and Devices Product and Services
    Table 139. Abbvie Contraceptives Drugs and Devices Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 140. Global Key Players of Contraceptives Drugs and Devices Upstream (Raw Materials)
    Table 141. Contraceptives Drugs and Devices Typical Customers
List of Figure
    Figure 1. Contraceptives Drugs and Devices Picture
    Figure 2. World Contraceptives Drugs and Devices Total Market Size: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Contraceptives Drugs and Devices Total Market Size (2018-2029) & (USD Million)
    Figure 4. World Contraceptives Drugs and Devices Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
    Figure 5. World Contraceptives Drugs and Devices Revenue Market Share by Region (2018-2029), (by Headquarter Location)
    Figure 6. United States Based Company Contraceptives Drugs and Devices Revenue (2018-2029) & (USD Million)
    Figure 7. China Based Company Contraceptives Drugs and Devices Revenue (2018-2029) & (USD Million)
    Figure 8. Europe Based Company Contraceptives Drugs and Devices Revenue (2018-2029) & (USD Million)
    Figure 9. Japan Based Company Contraceptives Drugs and Devices Revenue (2018-2029) & (USD Million)
    Figure 10. South Korea Based Company Contraceptives Drugs and Devices Revenue (2018-2029) & (USD Million)
    Figure 11. ASEAN Based Company Contraceptives Drugs and Devices Revenue (2018-2029) & (USD Million)
    Figure 12. India Based Company Contraceptives Drugs and Devices Revenue (2018-2029) & (USD Million)
    Figure 13. Contraceptives Drugs and Devices Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Contraceptives Drugs and Devices Consumption Value (2018-2029) & (USD Million)
    Figure 16. World Contraceptives Drugs and Devices Consumption Value Market Share by Region (2018-2029)
    Figure 17. United States Contraceptives Drugs and Devices Consumption Value (2018-2029) & (USD Million)
    Figure 18. China Contraceptives Drugs and Devices Consumption Value (2018-2029) & (USD Million)
    Figure 19. Europe Contraceptives Drugs and Devices Consumption Value (2018-2029) & (USD Million)
    Figure 20. Japan Contraceptives Drugs and Devices Consumption Value (2018-2029) & (USD Million)
    Figure 21. South Korea Contraceptives Drugs and Devices Consumption Value (2018-2029) & (USD Million)
    Figure 22. ASEAN Contraceptives Drugs and Devices Consumption Value (2018-2029) & (USD Million)
    Figure 23. India Contraceptives Drugs and Devices Consumption Value (2018-2029) & (USD Million)
    Figure 24. Producer Shipments of Contraceptives Drugs and Devices by Player Revenue ($MM) and Market Share (%): 2022
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Contraceptives Drugs and Devices Markets in 2022
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Contraceptives Drugs and Devices Markets in 2022
    Figure 27. United States VS China: Contraceptives Drugs and Devices Revenue Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Contraceptives Drugs and Devices Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. World Contraceptives Drugs and Devices Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Figure 30. World Contraceptives Drugs and Devices Market Size Market Share by Type in 2022
    Figure 31. Contraceptive Drugs (Oral Contraceptive Pills, Contraceptive Injectables, Topical Contraceptives)
    Figure 32. Contraceptive Devices (Male Contraceptive Devices, Female Contraceptive Devices)
    Figure 33. World Contraceptives Drugs and Devices Market Size Market Share by Type (2018-2029)
    Figure 34. World Contraceptives Drugs and Devices Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Figure 35. World Contraceptives Drugs and Devices Market Size Market Share by Application in 2022
    Figure 36. Female
    Figure 37. Male
    Figure 38. Contraceptives Drugs and Devices Industrial Chain
    Figure 39. Methodology
    Figure 40. Research Process and Data Source

Companies Mentioned

Teva Pharmaceutical Industries Ltd
Church & Dwight Co. Inc
Reckitt Benckiser Plc
Pfizer, Inc
Bayer AG
Mayer Laboratories, Inc
The Female Health Company
Cooper Surgical, Inc
Allergan plc
Cipla Limited
Merck & Co. Inc
Veru, Inc
Organon Group of Companies
Agile Therapeutics
TherapeuticsmMD, Inc
Afaxys, Inc
Mithra Pharmaceuticals
Abbvie